| RS2105889878 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS2105889888 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105889917 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105889931 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105890052 |
SCN1A
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Severe myoclonic epilepsy in infancy |
| RS2105890296 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105890375 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105890490 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105890565 |
SCN3A
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2105890879 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105891209 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105891349 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105891596 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105892972 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 62 |
| RS2105894081 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105894253 |
CERKL
|
Health Risk |
Pathogenic |
— |
| RS2105895111 |
SCN3A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105895501 |
SLC25A12
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 39 |
| RS2105899026 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105899169 |
TMEM237
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 14, Joubert syndrome 14 |
| RS2105899200 |
TMEM237
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2105899220 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS2105900297 |
TMEM237
|
Health Risk |
Likely pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS2105900861 |
TMEM237
|
Health Risk |
Pathogenic |
Joubert syndrome 14, Joubert syndrome 14 |
| RS2105901693 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Migraine, familial hemiplegic |
| RS2105901754 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105901763 |
CPS1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, neonatal |
| RS2105902170 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105902326 |
TMEM237
|
Health Risk |
Likely pathogenic |
— |
| RS2105902354 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105902403 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105902424 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105902476 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105902701 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105902725 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105907969 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105908864 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2105909854 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105909995 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS2105910926 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2105912281 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105912644 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105912800 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105917488 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS2105917562 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS2105917674 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105917940 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2105918357 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105918428 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105918665 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS2105920599 |
CPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2105922845 |
CPS1
|
Health Risk |
Likely pathogenic |
Congenital hyperammonemia, type I |
| RS2105922857 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105926082 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105928778 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105928782 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105928888 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105931529 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS2105934712 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105935255 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105942900 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105945363 |
NDUFS1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS2105945930 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS2105947080 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105952039 |
HIBCH
|
Health Risk |
Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS2105957137 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS2105959576 |
BMPR2
|
Health Risk |
Likely pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2105959685 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2105959713 |
BMPR2
|
Health Risk |
Pathogenic |
— |
| RS2105959754 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105961269 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS2105962254 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary arterial hypertension, Idiopathic and/or familial pulmonary arterial hypertension |
| RS2105962353 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2105962382 |
BMPR2
|
Health Risk |
Pathogenic |
— |
| RS2105962408 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS2105967839 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS2105967878 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS2105967973 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2105968169 |
NDUFS1
|
Health Risk |
Pathogenic |
— |
| RS2105969251 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS2105972075 |
ALS2
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS2105973807 |
NDUFS1
|
Health Risk |
Pathogenic |
— |
| RS2105976883 |
NDUFS1
|
Health Risk |
Likely pathogenic |
— |
| RS2105978931 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105978950 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105979879 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105980153 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105980214 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981050 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981099 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981231 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981299 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981467 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS2105981661 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105982029 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105982105 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105982111 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS2105982276 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS2105982797 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2105982815 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |